Alison Chandler is a pharmacist who is specialized in Geriatric in Durham, North Carolina. Patients can reach her at 605 Poplar St, Durham or contact her on 850-549-8090. Active license number of Alison Chandler is 21810 for Geriatric in North Dakota. Alison Chandler is a pharmacist who is certified in geriatric pharmacy practice is designated as a “Certified Geriatric Pharmacist” (CGP). To become certified, candidates are expected to be knowledgeable about principles of geriatric pharmacotherapy and the provision of pharmaceutical care to the elderly.
Complete Profile:
Alison Chandler speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Alison Chandler
Specialization:
Geriatric
Gender:
Female
Location:
605 Poplar St, Durham, North Carolina, 27703-9439
Phone:
850-549-8090
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Alison Chandler are as mentioned below.
NPI Number:
1033570932
NPI Enumeration Date:
19 Mar, 2016
NPI Last Update On:
19 Mar, 2016
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Alison Chandler are as mentioned below.
Specialization
License Number
State
Status
Geriatric
21810
North Dakota
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2301 Erwin Rd, Durham, North Carolina
Zip:
27705-4699
Phone Number:
--
Fax Number:
--
Patients can reach Alison Chandler at 605 Poplar St, Durham, North Carolina or can call on phone at 850-549-8090.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.